Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pruritus × Dermatologic × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Melanoma 383 Carcinoma, Non-Small-Cell Lung 78 Neoplasm Metastasis 62 Neoplasms 55 Carcinoma, Renal Cell 47 Lymphoma, T-Cell, Cutaneous 46 Ovarian Neoplasms 40 Squamous Cell Carcinoma of Head and Neck 38 Colorectal Neoplasms 35 Breast Neoplasms 33 Stomach Neoplasms 32 Skin Neoplasms 32 Lymphoma 30 Carcinoma, Merkel Cell 29 Uveal Melanoma 28 Mycosis Fungoides 28 Triple Negative Breast Neoplasms 26 Lung Neoplasms 26 Sezary Syndrome 25 Lymphoma, Non-Hodgkin 24 Lymphoma, Follicular 23 Hodgkin Disease 23 Pancreatic Neoplasms 22 Carcinoma, Hepatocellular 22 Uterine Cervical Neoplasms 21 Endometrial Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Lymphoma, B-Cell, Marginal Zone 19 Sarcoma 18

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00863395 2014-03-31

CTCL

University of Minnesota

Phase 1/2 Terminated

DermatologicLymphoid

Pruritus, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡